Brookstone Capital Management boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 14.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,486 shares of the healthcare conglomerate’s stock after acquiring an additional 1,935 shares during the quarter. Brookstone Capital Management’s holdings in UnitedHealth Group were worth $7,826,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of UNH. Chelsea Counsel Co. purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $27,000. Freedom Wealth Alliance LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth about $31,000. Legend Financial Advisors Inc. purchased a new stake in UnitedHealth Group during the 3rd quarter worth about $37,000. Investors Research Corp increased its position in UnitedHealth Group by 51.1% during the 4th quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock worth $38,000 after purchasing an additional 24 shares in the last quarter. Finally, Bourgeon Capital Management LLC boosted its stake in UnitedHealth Group by 192.3% in the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock worth $40,000 after buying an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 92.61% of the company’s stock.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $627.00 to $564.00 in a report on Friday, June 16th. Raymond James reiterated a “strong-buy” rating and issued a $630.00 price objective on shares of UnitedHealth Group in a research report on Friday, April 14th. Cantor Fitzgerald initiated coverage on UnitedHealth Group in a research report on Thursday, April 20th. They issued an “overweight” rating and a $591.00 price objective on the stock. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. Finally, StockNews.com lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $592.68.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Free Report) last released its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The business had revenue of $91.93 billion for the quarter, compared to the consensus estimate of $89.77 billion. During the same quarter in the previous year, the business earned $5.49 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.7% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 24.86 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were given a dividend of $1.88 per share. The ex-dividend date was Thursday, June 15th. This represents a $7.52 dividend on an annualized basis and a yield of 1.56%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio is currently 34.39%.
Insider Buying and Selling
In related news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the sale, the chief executive officer now owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,684 shares of the firm’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $488.46, for a total transaction of $822,566.64. Following the completion of the transaction, the executive vice president now directly owns 8,675 shares of the company’s stock, valued at approximately $4,237,390.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The disclosure for this sale can be found here. Insiders have sold 8,852 shares of company stock valued at $4,313,962 over the last 90 days. 0.35% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- MarketBeat Week in Review – 6/26 – 6/30
- Tesla: Can Downgrades Make Sense After A 170% Rally?
- Buffett’s Berkshire Increases Stake In Occidental Petroleum (OXY)
- Rally Gains Momentum On Soft PCE Data
- Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
